| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Scynexis Inc (SCYX) has 7 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. SCYX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 853.1K | $816.7K | - | |
| Dir | 78.0K | $74.7K | - | |
| Dir | 74.0K | $70.8K | - | |
| Dir | 70.0K | $67.0K | - | |
| Dir | 69.6K | $66.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2018 | Angulo Gonzalez David | Chief Medical Officer | Buy | 7,000 | $1.27 | $8,890.00 | +6.9% | |
| Aug 23, 2018 | Taglietti Marco | Chief Executive Officer | Buy | 25,000 | $1.29 | $32,250.00 | +6.2% | |
| Mar 29, 2018 | Angulo Gonzalez David | Chief Medical Officer | Buy | 6,000 | $1.36 | $8,160.00 | +6.3% | |
| Mar 8, 2018 | Hastings David C | Director | Buy | 11,834 | $1.69 | $19,999.46 | +59.2% | |
| Mar 8, 2018 | Francois Eric | Chief Financial Officer | Buy | 5,917 | $1.69 | $9,999.73 | +31.1% | |
| Mar 8, 2018 | Angulo Gonzalez David | Chief Medical Officer | Buy | 7,000 | $1.39 | $9,730.00 | +7.9% | |
| Mar 8, 2018 | Sukenick Scott | General Counsel | Buy | 2,959 | $1.69 | $5,000.71 | New | |
| Mar 8, 2018 | Taglietti Marco | Chief Executive Officer | Buy | 100,000 | $1.69 | $169,000.00 | +32.9% | |
| Mar 8, 2018 | Angulo Gonzalez David | Chief Medical Officer | Buy | 14,790 | $1.69 | $24,995.10 | +20.0% | |
| Sep 22, 2017 | Taglietti Marco | Chief Executive Officer | Buy | 10,000 | $2.23 | $22,300.00 | +3.4% |